Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Pata, Supansa ^a   Otáhal, Pavel ^b   Brdikča, Tomáš ^b   Laopajon, Witida ^a   Mahasongkram, Kodchakorn ^a   Kasinrerk, Watchara ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80051586103     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-293     Document Type: Article

References (47)

1. T-cell-antigen recognition and the immunological synapse. Huppa JB, Davis MM, Nat Rev Immunol 2003 3 973 983 10.1038/nri1245 14647479 (Pubitemid 37521539)
2. Functional anatomy of T cell activation and synapse formation. Fooksman DR, Vardhana S, Vasiliver-Shamis G, Liese J, Blair DA, Waite J, Sacristan C, Victora GD, Zanin-Zhorov A, Dustin ML, Annu Rev Immunol 2010 28 79 105 10.1146/annurev-immunol-030409-101308 19968559
3. Costimulatory regulation of T cell function. Chambers CA, Allison JP, Curr Opin Cell Biol 1999 11 203 210 10.1016/S0955-0674(99)80027-1 10209159 (Pubitemid 29164035)
4. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Oh KI, Kim BK, Ban YL, Choi EY, Jung KC, Lee IS, Park SH, Exp Mol Med 2007 39 176 184 17464179
5. A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes. Bernard A, Aubrit F, Raynal B, Pham D, Boumsell L, J Immunol 1988 140 1802 1807 2894395
6. The biochemical characterization of E2, a T cell surface molecule involved in rosettes. Aubrit F, Gelin C, Pham D, Raynal B, Bernard A, Eur J Immunol 1989 19 1431 1436 10.1002/eji.1830190813 2789140 (Pubitemid 19221049)
7. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. Gelin C, Aubrit F, Phalipon A, Raynal B, Cole S, Kaczorek M, Bernard A, EMBO J 1989 8 3253 3259 2479542 (Pubitemid 19273551)
8. MIC2: a human pseudoautosomal gene. Goodfellow PN, Pym B, Pritchard C, Ellis N, Palmer M, Smith M, Goodfellow PJ, Philos Trans R Soc Lond B Biol Sci 1988 322 145 154 10.1098/rstb.1988.0122 2907798
9. The MIC2 gene product: epitope mapping and structural prediction analysis define an integral membrane protein. Banting GS, Pym B, Darling SM, Goodfellow PN, Mol Immunol 1989 26 181 188 10.1016/0161-5890(89)90100-4 2465491 (Pubitemid 19031183)
10. CD99 (MIC2) expression in paediatric B-lineage leukaemia/lymphoma reflects maturation-associated patterns of normal B-lymphopoiesis. Dworzak MN, Fritsch G, Fleischer C, Printz D, Froschl G, Buchinger P, Mann G, Gadner H, Br J Haematol 1999 105 690 695 10.1046/j.1365-2141.1999.01426.x 10354133 (Pubitemid 29277027)
11. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease. Dworzak MN, Froschl G, Printz D, Zen LD, Gaipa G, Ratei R, Basso G, Biondi A, Ludwig WD, Gadner H, Leukemia 2004 18 703 708 10.1038/sj.leu.2403303 14961034 (Pubitemid 38500188)
12. CD99-positive "Ewing's sarcoma" from mouse-bone marrow-derived mesenchymal progenitor cells? Kovar H, Bernard A, Cancer Res 2006 66 9786; author reply 9786 17018640 (Pubitemid 44623681)
13. CD99 monoclonal antibody induce homotypic adhesion of Jurkat cells through protein tyrosine kinase and protein kinase C-dependent pathway. Kasinrerk W, Tokrasinwit N, Moonsom S, Stockinger H, Immunol Lett 2000 71 33 41 10.1016/S0165-2478(99)00165-0 10709783 (Pubitemid 30068609)
14. Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99/1 and MT99/2. Khunkaewla P, Chiampanichayakul S, Yasamut U, Pata S, Kasinrerk W, Hybridoma (Larchmt) 2007 26 241 250 10.1089/hyb.2007.0504 (Pubitemid 47331020)
15. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ, Baumruker T, Stockl J, Ebner C, Knapp W, Pickl WF, J Immunol 1998 161 4671 4678 9794396 (Pubitemid 28492041)
16. Apoptosis of immature thymocytes mediated by E2/CD99. Bernard G, Breittmayer JP, de Matteis M, Trampont P, Hofman P, Senik A, Bernard A, J Immunol 1997 158 2543 2550 9058785 (Pubitemid 127470509)
17. CD99 engagement: an effective therapeutic strategy for Ewing tumors. Scotlandi K, Baldini N, Cerisano V, Manara MC, Benini S, Serra M, Lollini PL, Nanni P, Nicoletti G, Bernard G, et al. Cancer Res 2000 60 5134 5142 11016640
18. CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Bernard G, Raimondi V, Alberti I, Pourtein M, Widjenes J, Ticchioni M, Bernard A, Eur J Immunol 2000 30 3061 3065 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M 11069091
19. CD99 plays a major role in the migration of monocytes through endothelial junctions. Schenkel AR, Mamdouh Z, Chen X, Liebman RM, Muller WA, Nat Immunol 2002 3 143 150 11812991 (Pubitemid 34141444)
20. Human leukocyte transmigration across Galalpha(1, 3)Gal-negative porcine endothelium is regulated by human CD18 and CD99. Schneider MK, Ghielmetti M, Rhyner DM, Antsiferova MA, Seebach JD, Transplantation 2009 87 491 499 10.1097/TP.0b013e318195fb8d 19307784
21. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. Bernard G, Zoccola D, Deckert M, Breittmayer JP, Aussel C, Bernard A, J Immunol 1995 154 26 32 7527813
22. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, Chung DH, Kim TJ, Lee WJ, Park CK, et al. J Immunol 1997 159 2250 2258 9278313 (Pubitemid 127681015)
23. CD99 is a key mediator of the transendothelial migration of neutrophils. Lou O, Alcaide P, Luscinskas FW, Muller WA, J Immunol 2007 178 1136 1143 17202377 (Pubitemid 46095186)
24. Gingipains of Porphyromonas gingivalis modulate leukocyte adhesion molecule expression induced in human endothelial cells by ligation of CD99. Yun PL, Decarlo AA, Hunter N, Infect Immun 2006 74 1661 1672 10.1128/IAI.74.3.1661- 1672.2006 16495537 (Pubitemid 43346799)
25. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes. Choi EY, Park WS, Jung KC, Kim SH, Kim YY, Lee WJ, Park SH, J Immunol 1998 161 749 754 9670951 (Pubitemid 28323538)
26. Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Bremond A, Meynet O, Mahiddine K, Coito S, Tichet M, Scotlandi K, Breittmayer JP, Gounon P, Gleeson PA, Bernard A, Bernard G, Blood 2009 113 347 357 18849489
27. A role for CD99 in T cell activation. Wingett D, Forcier K, Nielson CP, Cell Immunol 1999 193 17 23 10.1006/cimm.1999.1470 10202109 (Pubitemid 29197516)
28. Differential activation of MAP kinase family members triggered by CD99 engagement. Hahn MJ, Yoon SS, Sohn HW, Song HG, Park SH, Kim TJ, FEBS Lett 2000 470 350 354 10.1016/S0014-5793(00)01330-2 10745095 (Pubitemid 30169291)
29. Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells. Lee HJ, Kim E, Jee B, Hahn JH, Han K, Jung KC, Park SH, Lee H, Exp Mol Med 2002 34 177 183 12216109
30. CD99 isoforms expression dictates T cell functional outcomes. Alberti I, Bernard G, Rouquette-Jazdanian AK, Pelassy C, Pourtein M, Aussel C, Bernard A, FASEB J 2002 16 1946 1948 12368226
31. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways. Byun HJ, Hong IK, Kim E, Jin YJ, Jeoung DI, Hahn JH, Kim YM, Park SH, Lee H, J Biol Chem 2006 281 34833 34847 10.1074/jbc.M605483200 16984917 (Pubitemid 46036523)
32. CD99 regulates the transport of MHC class I molecules from the Golgi complex to the cell surface. Sohn HW, Shin YK, Lee IS, Bae YM, Suh YH, Kim MK, Kim TJ, Jung KC, Park WS, Park CS, et al. J Immunol 2001 166 787 794 11145651
33. Tetraspanins. Boucheix C, Rubinstein E, Cell Mol Life Sci 2001 58 1189 1205 10.1007/PL00000933 11577978 (Pubitemid 32844093)
34. Tetraspanins: molecular organisers of the leukocyte surface. Tarrant JM, Robb L, van Spriel AB, Wright MD, Trends Immunol 2003 24 610 617 10.1016/j.it.2003.09.011 14596886 (Pubitemid 37338530)
35. The tetraspanin web modulates immune-signalling complexes. Levy S, Shoham T, Nat Rev Immunol 2005 5 136 148 10.1038/nri1548 15688041 (Pubitemid 40208903)
36. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S, J Immunol 1996 157 2939 2946 8816400 (Pubitemid 126450050)
37. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. Schick MR, Levy S, J Immunol 1993 151 4090 4097 8409388 (Pubitemid 23298741)
38. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. Brdicka T, Imrich M, Angelisova P, Brdickova N, Horvath O, Spicka J, Hilgert I, Luskova P, Draber P, Novak P, et al. J Exp Med 2002 196 1617 1626 10.1084/jem.20021405 12486104 (Pubitemid 36026473)
39. Control of immune responses by trafficking cell surface proteins, vesicles and lipid rafts to and from the immunological synapse. Taner SB, Onfelt B, Pirinen NJ, McCann FE, Magee AI, Davis DM, Traffic 2004 5 651 661 10.1111/j.1600-0854.2004.00214.x 15296490 (Pubitemid 39199129)
40. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Levy S, Todd SC, Maecker HT, Annu Rev Immunol 1998 16 89 109 10.1146/annurev.immunol.16.1.89 9597125 (Pubitemid 28183360)
41. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Scotlandi K, Zuntini M, Manara MC, Sciandra M, Rocchi A, Benini S, Nicoletti G, Bernard G, Nanni P, Lollini PL, et al. Oncogene 2007 26 6604 6618 10.1038/sj.onc.1210481 17471235 (Pubitemid 47573680)
42. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Yauch RL, Hemler ME, Biochem J 2000 351 Pt 3 629 637 11042117
43. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. Zhang XA, Bontrager AL, Hemler ME, J Biol Chem 2001 276 25005 25013 10.1074/jbc.M102156200 11325968
44. Association of the transmembrane 4 superfamily molecule CD53 with a tyrosine phosphatase activity. Carmo AM, Wright MD, Eur J Immunol 1995 25 2090 2095 10.1002/eji.1830250743 7621882
45. The immunological synapse, TCR microclusters, and T cell activation. Yokosuka T, Saito T, Curr Top Microbiol Immunol 2010 340 81 107 10.1007/978-3-642-03858-7-5 19960310
46. Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. Mittelbrunn M, Yanez-Mo M, Sancho D, Ursa A, Sanchez-Madrid F, J Immunol 2002 169 6691 6695 12471100 (Pubitemid 36899253)
47. A new type of membrane raft-like microdomains and their possible involvement in TCR signaling. Otahal P, Angelisova P, Hrdinka M, Brdicka T, Novak P, Drbal K, Horejsi V, J Immunol 2010 184 3689 3696 10.4049/jimmunol. 0902075 20207997